PharmaShots Weekly Snapshot (October 21-25, 2019)
1. Urology San Antonio Collaborates with Anixa Biosciences on Ccheck Prostate Cancer Study
Published: Oct 25, 2019 | Tags: Urology San Antonio, Collaborates, Anixa Biosciences, Ccheck, Prostate Cancer Study
??2. NHS England Signs an Agreement with Vertex to Access All Licensed Cystic Fibrosis Therapies
Published: Oct 24, 2019 | Tags: NHS England, Signs, Agreement, Vertex, Access, Licensed, Cystic Fibrosis Therapies
??3. Zentiva to Acquire Alvogens Generics and OTC Business in Central and Eastern Europe
Published: Oct 25, 2019 | Tags: Zentiva, Acquire, Alvogen, Generics, OTC, Business, Central and Eastern Europe
Published: Oct 25, 2019 | Tags: Astellas, Xospata, gilteritinib, Receives, EC, Approval, Monotherapy, Relapsed, Refractory, Acute Myeloid Leukemia, FLT3 Mutation
Published: Oct 24, 2019 | Tags: Allergan, BOTOX, onabotulinumtoxinA, Receives, US, FDA, Approval, Pediatric Patients, Lower Limb Spasticity, Spasticity Caused by Cerebral Palsy
??6. ?AbbVie Collaborate with Cystic Fibrosis Foundation to Advance CFTR Potentiator
Published: Oct 24, 2019 | Tags: AbbVie, Collaborate, Cystic Fibrosis Foundation, Advance, CFTR Potentiator
??7. NovoCodex Collaborates with Ambrx to Develop and Commercialize its ARX305 in China
Published: Oct 23, 2019 | Tags: NovoCodex, Collaborates, Ambrx, Develop, Commercialize, ARX305, China
8. ??WHO Signs MoU with IGBA for Promoting the Access to Biosimilars and Generics
Published: Oct 23, 2019 | Tags: WHO, Signs, MoU, IGBA, Promote, Access, Biosimilars, Generics
Published: Oct 24, 2019 | Tags: Bausch Health, In-Licenses, Clearside, Xipere, triamcinolone acetonide suprachoroidal injectable suspension, Macular Edema Associated with Uveitis
Published: Oct 23, 2019 | Tags: GSK, Zejula, niraparib, Receives, FDA, Approval, Late-line Treatment, Women, Recurrent Ovarian Cancer
11. ?Novartis Collaborates with Pliant Therapeutics to Develop Therapies for NASH and Fibrotic Diseases
Published: Oct 24, 2019 | Tags: Novartis, Collaborates, Pliant Therapeutics, Develop, Therapies, NASH, Fibrotic Diseases
Published: Oct 23, 2019 | Tags: Biomica, Signs, Agreement, Weizmann Institute of Science, Develop, Selective, Treatment, Against, Antibiotic Resistant Bacteria
Published: Oct 22, 2019 | Tags: Brii Biosciences, Collaborates, Qpex, Develop, Commercialize, Antibiotics, Drug-Resistant Infections, China
Published: Oct 22, 2019 | Tags: BerGenBio, Bemcentinib, Receives, US, FDA, Fast Track Designation, Relapsed Acute Myeloid Leukemia
?15. Biogen and Eisai Plan to File BLA to the US FDA for Aducanumab to Treat Alzheimers Disease
Published: Oct 22, 2019 | Tags: Biogen, Eisai, Plan, File, BLA, US, FDA, Aducanumab, Treat, Alzheimers Disease
Published: Oct 22, 2019 | Tags: Novo Nordisk, Fiasp, insulin aspart injection, Insulin Infusion Pumps, Type 1 Diabetes, Type 2 Diabetes
Published: Oct 21, 2019 | Tags: Alvogen, Signs, Exclusive, Commercialization Agreement, Three, Pharma Companies, PF708, biosimilar, teriparatide
Published: Oct 22, 2019 | Tags: BMS, Reports, Result, Opdivo, nivolumab, Yervoy, ipilimumab, CT, P-III, CheckMate-9LA, 1L, Lung Cancer
Published: Oct 21, 2019 | Tags: Vertex, Trikafta, elexacaftor, tezacaftor, ivacaftor, Receives, US, FDA, Approval, Treat, Cystic Fibrosis
Published: Oct 21, 2019 | Tags: Pfizer, OPKO, Reports, Results, Somatrogon, P-III, Study, Children, Growth Hormone Deficiency
?21. Takeda Acquires Exclusive Worldwide License Rights for COURs CNP-101 to Treat Celiac Disease
Published: Oct 22, 2019 | Tags: Takeda, Acquires, Exclusive, Worldwide, License, COUR, CNP-101, Celiac Disease
22. ??Bayer to Terminate its JV Agreement with CRISPR Therapeutics
Published: Oct 21, 2019 | Tags: CRISPR, Casebia Therapeutics, Terminating, JV agreement, Bayer
Published: Oct 21, 2019 | Tags: Humana, Microsoft, Collaborate, Reimagine, Health, Leveraging, Azure Cloud, AI, Voice Technologies
Published: Oct 21, 2019 | Tags: Janssen, Stelara, ustekinumab, Receives, US, FDA, Approval, Moderately to Severely Active Ulcerative Colitis
?25. Sartorius to Acquire Danahers Life Science Portfolio for $750M
Published: Oct 21, 2019 | Tags: Sartorius, Acquire, Danaher, Life Science Portfolio, $750M
Published: Oct 21, 2019 | Tags: AstraZeneca, Farxiga, dapagliflozin, Receives, US, FDA, Approval, Reducing, Risk of Hospitalization, Heart Failure, Patients, Type-2 Diabetes
27. GSK to Divest its Rabipur and Encepur Vaccines to Bavarian Nordic for ~1B
Published: Oct 21, 2019 | Tags: GSK, Divest, Rabipur, Encepur, Vaccines, Bavarian Nordic, ~1B
Published: Oct 21, 2019 | Tags: Roche, Reports, Result, Tecentriq, atezolizumab, Avastin, bevacizumab, P-III, IMbrave150, Study, Unresectable Hepatocellular Carcinoma
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com